𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation and quantitation of proteomic biomarkers for severe preeclampsia in cerebrospinal fluid

✍ Scribed by Errol Norwitz; Lawrence Tsen; Joong-Shin Park; Patricia Fitzpatrick; David Dorfman; Catalin Buhimschi; George Saade; Charles Lockwood; Irina Buhimschi

Book ID
113428288
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
72 KB
Volume
191
Category
Article
ISSN
1097-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Proteomics of human cerebrospinal fluid:
Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics
✍ A.C. Kroksveen; J.A. Opsahl; T.T. Aye; R.J. Ulvik; F.S. Berven πŸ“‚ Article πŸ“… 2011 πŸ› Elsevier 🌐 English βš– 737 KB

There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases. Cerebrospinal fluid (CSF) is in direct contact with the CNS and reflects

Proteomic identification of biomarkers i
Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration
✍ I. Rite; S. ArgΓΌelles; J.L. Venero; S. GarcΓ­a-Rodriguez; A. Ayala; J. Cano; A. M πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 623 KB

## Abstract We have performed proteomic analysis in the cerebrospinal fluid in an animal model of Parkinson's disease induced by axotomy of the medial forebrain bundle. In this model, the degeneration of dopaminergic neurons was completed in 14 days, with a loss of about 50% dopaminergic neurons in